Cooley Godward LLP will be hosting the event Accelerating Clinical Trials with Biomarkers on December 6, 2005 from 9 a.m. to 4 p.m., which will be held at its offices at 3175 Hanover Street, Palo Alto, CA 94304-1130. The workshop will focus on the incorporation of biomarkers into clinical trials, biomarker discovery, biomarker assay development, and biomarker validation. The confirmed speakers for this event include Mark McCamish, M.D., CMO, Perlegen; Pamela Contag, Ph.D., President, Xenogen; Robert McCormack, M.D., Veridex; Nancy Mize, Ph.D., Pacific BioDevelopment; and Cameron Carter, M.D., Director, Imaging Research Center.